Sulwhasoo Perfecting Cushion NO.23N1 Sand 1.05 g/15g
OCTINOXATE, TITANIUM DIOXIDE, and HOMOSALATE · LOTION · Amorepacific Corporation
Sulwhasoo Perfecting Cushion NO.23N1 Sand is a lotion containing octinoxate, titanium dioxide, and homosalate at 1.05 g/15g, taken topical. Manufactured by Amorepacific Corporation.
Key Facts
- Brand Name
- Sulwhasoo Perfecting Cushion NO.23N1 Sand
- Generic Name
- OCTINOXATE, TITANIUM DIOXIDE, and HOMOSALATE
- NDC Code (Product)
43419-089- Manufacturer
- Amorepacific Corporation
- Strength
- 1.05 g/15g
- Dosage Form
- LOTION
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 01/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Sulwhasoo Perfecting Cushion NO.23N1 Sand used for?
Sulwhasoo Perfecting Cushion NO.23N1 Sand contains OCTINOXATE, TITANIUM DIOXIDE, and HOMOSALATE. It is a lotion taken topical. Consult your doctor for specific uses.
Is Sulwhasoo Perfecting Cushion NO.23N1 Sand a controlled substance?
Sulwhasoo Perfecting Cushion NO.23N1 Sand is not classified as a controlled substance by the DEA.
What is the generic name for Sulwhasoo Perfecting Cushion NO.23N1 Sand?
The generic name for Sulwhasoo Perfecting Cushion NO.23N1 Sand is OCTINOXATE, TITANIUM DIOXIDE, and HOMOSALATE. There are 6 other brand versions of OCTINOXATE, TITANIUM DIOXIDE, and HOMOSALATE.
What is the NDC code for Sulwhasoo Perfecting Cushion NO.23N1 Sand 1.05 g/15g?
The NDC (National Drug Code) for Sulwhasoo Perfecting Cushion NO.23N1 Sand 1.05 g/15g is 43419-089, listed by Amorepacific Corporation.
Other Octinoxate, Brands
See all →- Sulwhasoo Perfecting Cushion NO.33C1 Walnut1.05 g/15g43419-092
- Sulwhasoo Perfecting Cushion NO.25N1 Amber1.05 g/15g43419-090
- Sulwhasoo Perfecting Cushion NO.31W1 Almond1.05 g/15g43419-091
- Sulwhasoo Perfecting Cushion NO.37W1 Maple1.05 g/15g43419-093
- Sulwhasoo Perfecting Cushion NO.21N1 Beige1.05 g/15g43419-087
- Sulwhasoo Perfecting Cushion NO.17N1 Vanilla1.05 g/15g43419-086
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)